June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Neuroprotection from excitotoxic RGC death: is there a role for MMPs?
Author Affiliations & Notes
  • Lies De Groef
    Department of Biology, Laboratory for Neural Circuit Development and Regeneration, KU Leuven, Leuven, Belgium
  • Manuel Salinas-Navarro
    Department of Biology, Laboratory for Neural Circuit Development and Regeneration, KU Leuven, Leuven, Belgium
  • Eline Dekeyster
    Department of Biology, Laboratory for Neural Circuit Development and Regeneration, KU Leuven, Leuven, Belgium
  • Kim Lemmens
    Department of Biology, Laboratory for Neural Circuit Development and Regeneration, KU Leuven, Leuven, Belgium
  • Djoere Gaublomme
    Department of Biology, Laboratory for Neural Circuit Development and Regeneration, KU Leuven, Leuven, Belgium
  • Inge Van Hove
    Department of Biology, Laboratory for Neural Circuit Development and Regeneration, KU Leuven, Leuven, Belgium
  • Lieve Moons
    Department of Biology, Laboratory for Neural Circuit Development and Regeneration, KU Leuven, Leuven, Belgium
  • Footnotes
    Commercial Relationships Lies De Groef, None; Manuel Salinas-Navarro, None; Eline Dekeyster, None; Kim Lemmens, None; Djoere Gaublomme, None; Inge Van Hove, None; Lieve Moons, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4943. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lies De Groef, Manuel Salinas-Navarro, Eline Dekeyster, Kim Lemmens, Djoere Gaublomme, Inge Van Hove, Lieve Moons; Neuroprotection from excitotoxic RGC death: is there a role for MMPs?. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4943.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Multiple studies in glaucoma patients and animal models, have reported differential expression and activity of matrix metalloproteinase (MMPs). These data have led to the hypothesis that MMPs are involved in glaucoma pathogenesis. However, their in vivo functions remain poorly understood. Here, we investigate the contribution of MMPs to retinal ganglion cell (RGC) death in the excitotoxic mouse retina and reveal that MMP-2, -3 and -9 deficient mice are -at least partially- protected from excitotoxic RGC death.

Methods: Excitotoxic RGC death was induced via intravitreal injection of 20 mM NMDA, both in wild type and MMP-2, -3 or -9 deficient mice (N>5). Expression of MMPs was examined via immunohistochemistry and Western blot. RGC survival was assessed by quantifying the number of survival RGCs after Brn3a immunostaining on whole mounted retinas using a custom-made automated routine.

Results: MMP-9 is expressed by RGCs and microglia and also shows strong immunoreactivity in the inner limiting membrane. MMP-2 and -3, on the other hand, have a macroglial origin and are expressed throughout all layers of the mouse retina. At 24 hours post NMDA injection (24hpi), a strong upregulation of MMP-3 and -9 expression is seen, whereas MMP-2 levels only increase modestly. MMP-9 deficiency protects retinas from NMDA-induced RGC death. Also in MMP-2-/- and MMP-3-/- mice, RGC death is attenuated. Whereas only 17.0±0.05% of the RGCs survive in wild type mice at 24hpi, RGC survival is increased to 34.01±0.01% and 33.99±0.05% in, respectively, MMP-2-/- and MMP-3-/- animals. We are currently analyzing time-dependent cellular changes within the excitotoxic retina and investigating possible underlying mechanisms.

Conclusions: MMP-2, -3 and -9 deficiency reduces RGC death in an excitotoxic mouse glaucoma model. For MMP-9, this is in accordance to what has been shown in an optic nerve ligation glaucoma model and most likely related to anoikis of RGCs. On the other hand, for MMP-2 and -3, this neuroprotective effect might be related to modulation of the glial reactivity accompanying RGC degeneration, as suggested by their glial expression pattern.

Keywords: 615 neuroprotection  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×